311 research outputs found

    Politics at the Cutting Edge: Intergovernmental Policy Innovation in the Affordable Care Act

    Get PDF
    In the eight years since the passage of the Patient Protection and Affordable Care Act (ACA), state governments have remained critical sites of contention over the law. Intense partisan conflict over ACA implementation has raised questions about traditional theories of intergovernmental relations, which posit that federal–state cooperation depends largely on policy design. Yet, few studies have examined how partisanship, as well as other important factors, shape state policy innovations under the ACA. This article examines the ACA’s State Innovation Models (SIM) initiative. SIM is specifically geared towards incentivizing states to experiment with new models of payment and delivery that can improve health outcomes and/or reduce health-care costs. Drawing on a combination of quantitative and qualitative evidence, we find that states’ participation in SIM is shaped by partisanship, administrative capacity, and state policy legacies. Our findings have implications for future efforts at intergovernmental health reforms

    Responses of Massachusetts hospitals to a state mandate to collect race, ethnicity and language data from patients: a qualitative study

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>A Massachusetts regulation implemented in 2007 has required all acute care hospitals to report patients' race, ethnicity and preferred language using standardized methodology based on self-reported information from patients. This study assessed implementation of the regulation and its impact on the use of race and ethnicity data in performance monitoring and quality improvement within hospitals.</p> <p>Methods</p> <p>Thematic analysis of semi-structured interviews with executives from a representative sample of 28 Massachusetts hospitals in 2009.</p> <p>Results</p> <p>The number of hospitals using race, ethnicity and language data internally beyond refining interpreter services increased substantially from 11 to 21 after the regulation. Thirteen of these hospitals were utilizing patient race and ethnicity data to identify disparities in quality performance measures for a variety of clinical processes and outcomes, while 16 had developed patient services and community outreach programs based on findings from these data. Commonly reported barriers to data utilization include small numbers within categories, insufficient resources, information system requirements, and lack of direction from the state.</p> <p>Conclusions</p> <p>The responses of Massachusetts hospitals to this new state regulation indicate that requiring the collection of race, ethnicity and language data can be an effective method to promote performance monitoring and quality improvement, thereby setting the stage for federal standards and incentive programs to eliminate racial and ethnic disparities in the quality of health care.</p

    Financial impact of reducing door-to-balloon time in ST-elevation myocardial infarction: a single hospital experience

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>The impact of reducing door-to-balloon time on hospital revenues, costs, and net income is unknown.</p> <p>Methods</p> <p>We prospectively determined the impact on hospital finances of (1) emergency department physician activation of the catheterization lab and (2) immediate transfer of the patient to an immediately available catheterization lab by an in-house transfer team consisting of an emergency department nurse, a critical care unit nurse, and a chest pain unit nurse. We collected financial data for 52 consecutive ST-elevation myocardial infarction patients undergoing emergency percutaneous intervention from October 1, 2004–August 31, 2005 and compared this group to 80 consecutive ST-elevation myocardial infarction patients from September 1, 2005–June 26, 2006 after protocol implementation.</p> <p>Results</p> <p>Per hospital admission, insurance payments (hospital revenue) decreased (35,043±35,043 ± 36,670 vs. 25,329±25,329 ± 16,185, P = 0.039) along with total hospital costs (28,082±28,082 ± 31,453 vs. 18,195±18,195 ± 9,242, P = 0.009). Hospital net income per admission was unchanged (6962vs.6962 vs. 7134, P = 0.95) as the drop in hospital revenue equaled the drop in costs. For every 1000reductionintotalhospitalcosts,insurancepayments(hospitalrevenue)dropped1000 reduction in total hospital costs, insurance payments (hospital revenue) dropped 1077 for private payers and 1199forMedicare/Medicaid.Adecreaseinhospitalcharges(1199 for Medicare/Medicaid. A decrease in hospital charges (70,430 ± 74,033vs.74,033 vs. 53,514 ± 23,378,P=0.059),diagnosisrelatedgrouprelativeweight(3.7479±2.6731vs.2.9729±0.8545,P=0.017)andoutlierpaymentswithhospitalrevenue>23,378, P = 0.059), diagnosis related group relative weight (3.7479 ± 2.6731 vs. 2.9729 ± 0.8545, P = 0.017) and outlier payments with hospital revenue>100,000 (7.7% vs. 0%, P = 0.022) all contributed to decreasing ST-elevation myocardial infarction hospitalization revenue. One-year post-discharge financial follow-up revealed similar results: Insurance payments: 49,959±49,959 ± 53,741 vs. 35,937±35,937 ± 23,125, P = 0.044; Total hospital costs: 39,974±39,974 ± 37,434 vs. 26,778±26,778 ± 15,561, P = 0.007; Net Income: 9984vs.9984 vs. 9159, P = 0.855.</p> <p>Conclusion</p> <p>All of the financial benefits of reducing door-to-balloon time in ST-elevation myocardial infarction go to payers both during initial hospitalization and after one-year follow-up.</p> <p>Trial Registration</p> <p><b>ClinicalTrials.gov ID</b>: NCT00800163</p
    • 

    corecore